Astrazeneca (AZN) EV to EBIT (2009 - 2026)
Astrazeneca's EV to EBIT was 16.41 in Q3 2026, down 8.6% from 17.95 a year earlier and down 20.7% from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) EV to EBIT (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Astrazeneca's EV to EBIT was 15.18 through Sep 30, 2026, down 8.3% year-over-year; for FY2025, it was 20.32, up 2.9% from FY2024.
- In earlier years, EV to EBIT was 19.75 in FY2024 (-20.2%), 24.74 in FY2023 (-54.3%), 54.17 in FY2022 (-67.1%) and 164.89 in FY2021 (+590.9%).
- The Q3 2026 figure marks the lowest quarterly EV to EBIT since Q3 2017.
- Compared with a year earlier, EV to EBIT was higher in two of the last eight quarters, with an average decline of 10.4%.
- The best year-over-year quarter for EV to EBIT over five years was Q4 2021 (growth of 590.5%); the worst was Q1 2023 (a decline of 99.2%).
- Per Business Quant data, AZN's EV to EBIT in the three quarters before Q3 2026 was 20.69 (Q2 2026), 20.83 (Q1 2026) and 20.32 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn |
| 10 | Vertex Pharmaceuticals | 139.96 Bn | 111.95 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 16.41 |
| Jun 30, 2026 | 20.69 |
| Mar 31, 2026 | 20.83 |
| Dec 31, 2025 | 20.32 |
| Sep 30, 2025 | 17.95 |
| Jun 30, 2025 | 18.51 |
| Mar 31, 2025 | 21.09 |
| Dec 31, 2024 | 19.76 |
| Sep 30, 2024 | 25.72 |
| Jun 30, 2024 | 25.95 |
| Mar 31, 2024 | 23.07 |
| Dec 31, 2023 | 24.76 |
| Sep 30, 2023 | 25.43 |
| Jun 30, 2023 | 29.40 |
| Mar 31, 2023 | 38.45 |
| Dec 31, 2022 | 54.25 |
| Sep 30, 2022 | 69.83 |
| Mar 31, 2022 | 5,123.88 |
| Dec 31, 2021 | 164.96 |
| Sep 30, 2021 | 53.16 |
API Access
Astrazeneca EV to EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebit", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();